2607.08602
2026-07-10
cs.AI
新提交
83%
Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance
迈向肝细胞癌的精准治疗:用于风险分层和治疗指导的临床推理大语言模型
Peng Cui, Jitao Wang, Siyan Xue, Yao Huang, Haoming Xia, Dong Li, Dengxiang Liu, Weilin Wang, Liping Liu, Leida Zhang, Yunfu Cui, Tao Peng, Daolin Ji, Haitao Zhao, Wei Zhang, Xiaojuan Wang, Weijie Ma, Zongren Ding, Jinlong Li, Yuan Ding, Jiajing Zhao, Zhiyu Chen, Chengkun Yang, Ziyue Huang, Jiaqi Liu, Fusheng Liu, Yang Zhou, Xiaojuan Wang, Zhongquan Sun, Shiyun Bao, Xiaojun Wang, Ming Yang, Guangxin Li, Bin Shu, Yong Liao, Hongxuan Li, Yao Tang, Shizhong Yang, Yongyi Zeng, Yufeng Yuan, Yinpeng Dong, Jihui Hao, Jun Zhu, Jiahong Dong
专题命中
领域大模型
:LLM(title);large language model(abstract);language model(abstract);分类 cs.AI
AI总结
研究针对肝细胞癌治疗问题,提出HCC-STAR临床推理大语言模型。通过处理电子病历叙述输出风险分层、治疗方案等。经多中心队列验证,性能领先,能助医生决策,是可靠的肝细胞癌风险分层和精准治疗决策支持系统。